Applied Genetic Technologies Corp.

Plus: AbbVie licenses TL1A mAb from FutureGen for IBD, and updates from Takeda, Ascentage, Pfizer, ProFound and more

Plus: After appeal, Ardelyx wins approval of kidney therapy, and updates from Mablink, Actym, Syncona, CDER and more

Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more

VCs back start-up in £96M series A, joining AGTC takeout with pair of preclinical programs

Plus: new commercial head at Karuna, and updates from Casma, CBER, Optinose, Rally Bio and more

Plus Alpine pivots and updates from Resolve, Imjudo, Syncona and more

Data for X-linked retinitis pigmentosa, geographic atrophy support moving into later-stage trials

Plus Duke to be CFO at Apexigen and updates from MC2, Pillar, Nonagen and more

Recludix, Ankyra unveil venture rounds and new execs; plus ImmunoGen, Talis, Kira, Sonoma, Spruce, Ankyra and more

Plus: Myriad, Kura, Ideaya, IASO, OncoCyte and more